ADAMTS13 Plays a Novel Role in Hyperfibrinolysis After Trauma-Induced Shock
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, reposted from Derek Kleinveld on LinkedIn:
”Thank you Derek Kleinveld for the opportunity to collaborate with my group.”
Quoting Derek Kleinveld‘s post:
”Happy to share our latest publication on a novel role for ADAMTS13 in trauma-induced shock. Thanks to all collaborators!”
Title: A novel role for ADAMTS13 in hyperfibrinolysis after trauma-induced shock
Authors: Pieter H. Sloos, Lisa Vermeersch, Daphne S. Roozendaal, Anne-Sophie Delmote, Cornelis van ‘t Veer, Thomas O. Momanyi, Frida Z. Miranda, Joshua Muia, Claudia Tersteeg, Karen Vanhoorelbeke, Nicole P. Juffermans, Derek J.B. Kleinveld
Read the full article here.
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Sep 24, 2026, 16:02Leonardo Roever: Understanding Peripheral Artery Disease in the Modern Era
-
Sep 24, 2026, 15:49Sthanu Subramanian: When HbA1c Does Not Reflect True Glycemia
-
Sep 24, 2026, 15:09Caroline Voltz-Girolt: Accelerating the Development of Innovative Therapies for Rare Blood Disorders
-
Sep 24, 2026, 15:00Gambo Ramatu: Anemia as a Preventable Pregnancy Challenge
-
Sep 24, 2026, 14:56Holly John: Sickle Cell Disease Beyond Pain and Clinical Outcomes
-
Sep 24, 2026, 14:45Bruce Holland: Ex Vivo Assessment of ActiGraft Clot Formation Under Anticoagulation
-
Sep 24, 2026, 14:33Mohamed El Belghiti Alaoui: Thrombin as a Therapeutic Target in Coagulation
-
Sep 24, 2026, 14:22Integrating Thrombosis Risk Into Menopause Care – World Thrombosis Day
-
Sep 24, 2026, 13:41Mahmoud Samir Bayomi: Raise ITP Awareness and Improve Patient Care